Literature DB >> 16932902

Long-term follow-up of patients with idiopathic infantile hypercalcaemia.

Jianping Huang1, David Coman, Steven J McTaggart, John R Burke.   

Abstract

Idiopathic infantile hypercalcaemia (IIH) is a rare disorder of unknown etiology that presents with hypercalcaemia in a child's first year of life. There is only a limited number of published reports of the natural history of this condition, and the long-term prognosis is largely unknown. The presentation, treatment and long-term follow-up of 11 children with IIH treated at our institution since 1993 are described. Hypercalcaemia resolved in the majority of children by the time they were 3 years of age, but nephrocalcinosis and persistent hypercalciuria were common, and, in some cases, urinary calcium excretion increased after initially becoming normal. This study suggests that clinical and biochemical abnormalities may persist for longer than previously reported and implies the need for ongoing surveillance of patients with IIH.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16932902     DOI: 10.1007/s00467-006-0217-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  17 in total

Review 1.  Expanding role of bisphosphonate therapy in children.

Authors:  L R Shoemaker
Journal:  J Pediatr       Date:  1999-03       Impact factor: 4.406

2.  [Chronic hyperglycemia, combined with osteosclerosis, hyperazotemia, nanism and congenital malformations].

Authors:  G FANCONI; P GIRARDET; B SCHLESINGER; N BUTLER; J BLACK
Journal:  Helv Paediatr Acta       Date:  1952-08

Review 3.  Hypercalcemia of the newborn: etiology, evaluation, and management.

Authors:  C Rodd; P Goodyer
Journal:  Pediatr Nephrol       Date:  1999-08       Impact factor: 3.714

4.  A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.

Authors:  G J Schwartz; G B Haycock; C M Edelmann; A Spitzer
Journal:  Pediatrics       Date:  1976-08       Impact factor: 7.124

5.  Idiopathic infantile hypercalcemia: rapid response to treatment with calcitonin.

Authors:  U Alon; D Berkowitz; M Berant
Journal:  Child Nephrol Urol       Date:  1992

6.  Clinical pharmacology of sodium cellulose phosphate.

Authors:  C Y Pak
Journal:  J Clin Pharmacol       Date:  1979 Aug-Sep       Impact factor: 3.126

7.  Prednisolone and cellulose phosphate treatment in idiopathic infantile hypercalcaemia with nephrocalcinosis.

Authors:  Y Mizusawa; J R Burke
Journal:  J Paediatr Child Health       Date:  1996-08       Impact factor: 1.954

8.  Cellulose phosphate and chlorothiazide in childhood idiopathic hypercalciuria.

Authors:  J R Burke; D M Cowley; B M Mottram; P Buckner
Journal:  Aust N Z J Med       Date:  1986-02

Review 9.  Renal calcification in the first year of life.

Authors:  M G Karlowicz; R D Adelman
Journal:  Pediatr Clin North Am       Date:  1995-12       Impact factor: 3.278

10.  Preterm neonates with nephrocalcinosis: natural course and renal function.

Authors:  Eveline A Schell-Feith; Joana E Kist-van Holthe; Paul H T van Zwieten; Harmine M Zonderland; Herma C Holscher; Dorine W Swinkels; Ronald Brand; Howard M Berger; Bert J van der Heijden
Journal:  Pediatr Nephrol       Date:  2003-10-02       Impact factor: 3.714

View more
  12 in total

1.  Genetic defect in CYP24A1, the vitamin D 24-hydroxylase gene, in a patient with severe infantile hypercalcemia.

Authors:  Andrew Dauber; Thutrang T Nguyen; Etienne Sochett; David E C Cole; Ronald Horst; Steven A Abrams; Thomas O Carpenter; Joel N Hirschhorn
Journal:  J Clin Endocrinol Metab       Date:  2011-11-23       Impact factor: 5.958

2.  Severe hypercalcaemia due to subcutaneous fat necrosis: presentation, management and complications.

Authors:  Daniel E Shumer; Vidhu Thaker; George A Taylor; Ari J Wassner
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2014-06-06       Impact factor: 5.747

3.  Idiopathic infantile hypercalcemia in children with chronic kidney disease due to kidney hypodysplasia.

Authors:  Evgenia Gurevich; Yael Borovitz; Shelli Levi; Sharon Perlman; Daniel Landau
Journal:  Pediatr Nephrol       Date:  2022-09-26       Impact factor: 3.651

4.  Severe hypercalcemic crisis in an infant with idiopathic infantile hypercalcemia caused by mutation in CYP24A1 gene.

Authors:  Filip Fencl; Květa Bláhová; Karl Peter Schlingmann; Martin Konrad; Tomáš Seeman
Journal:  Eur J Pediatr       Date:  2012-09-22       Impact factor: 3.183

5.  Medullary nephrocalcinosis in an adult patient with idiopathic infantile hypercalcaemia and a novel CYP24A1 mutation.

Authors:  Edgar Meusburger; Axel Mündlein; Emanuel Zitt; Barbara Obermayer-Pietsch; Dieter Kotzot; Karl Lhotta
Journal:  Clin Kidney J       Date:  2013-03-03

6.  Childhood Sustained Hypercalcemia: A Diagnostic Challenge.

Authors:  Nisa Eda Çullas İlarslan; Zeynep Şıklar; Merih Berberoğlu
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-04-26

7.  Mild Idiopathic Infantile Hypercalcemia-Part 2: A Longitudinal Observational Study.

Authors:  Nina Lenherr-Taube; Michelle Furman; Esther Assor; Yesmino Elia; Carol Collins; Kenneth Thummel; Michael A Levine; Etienne Sochett
Journal:  J Clin Endocrinol Metab       Date:  2021-09-27       Impact factor: 6.134

Review 8.  Hypercalcemic Disorders in Children.

Authors:  Victoria J Stokes; Morten F Nielsen; Fadil M Hannan; Rajesh V Thakker
Journal:  J Bone Miner Res       Date:  2017-11-02       Impact factor: 6.741

9.  Juvenile onset IIH and CYP24A1 mutations.

Authors:  Karl P Schlingmann; Walburga Cassar; Martin Konrad
Journal:  Bone Rep       Date:  2018-06-21

10.  Long-term outcome of the survivors of infantile hypercalcaemia with CYP24A1 and SLC34A1 mutations.

Authors:  Agnieszka Janiec; Paulina Halat-Wolska; Łukasz Obrycki; Elżbieta Ciara; Marek Wójcik; Paweł Płudowski; Aldona Wierzbicka; Ewa Kowalska; Janusz B Książyk; Zbigniew Kułaga; Ewa Pronicka; Mieczysław Litwin
Journal:  Nephrol Dial Transplant       Date:  2021-07-23       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.